This course has expired. Voir les cours disponibles.
Medication Management
Optimizing the Medical Management of Glaucoma for Pharmacists
As an initially asymptomatic disease, open angle glaucoma is the most common form of irreversible blindness in the world. Fortunately, vision loss may be slowed if effective treatment is initiated in a timely manner.
This program supports pharmacists in optimizing the medical management of patients with glaucoma by reviewing treatment options to ensure effective management of patients with glaucoma through the disease continuum. Using a case-study format, the program will review the treatment of glaucoma with topical agents, common situations that may prompt treatment adjustment, and strategies to optimize adherence to topical medications.
This program has received an educational grant or in-kind support from Allergan.
Durée
1 hr
Profession
Pharmacy
# des crédits
1.25
Accréditation
CCCEP
Date d'expiration
2022-11-16
As an initially asymptomatic disease, open angle glaucoma is the most common form of irreversible blindness in the world. Fortunately, vision loss may be slowed if effective treatment is initiated in a timely manner.
This program supports pharmacists in optimizing the medical management of patients with glaucoma by reviewing treatment options to ensure effective management of patients with glaucoma through the disease continuum. Using a case-study format, the program will review the treatment of glaucoma with topical agents, common situations that may prompt treatment adjustment, and strategies to optimize adherence to topical medications.
This program has received an educational grant or in-kind support from Allergan.
La Faculté
Luke Small, OD
Kelly Haggerty, BSc.Pharm, RPh, CTH, NCMP
Miguel Lopez-Dee, BSc Pharm, RPh
Objectifs d'apprentissage
Upon completion of this continuing education program, participants will be better able to:
- Define intraocular pressure (IOP) and describe its significance in glaucoma treatment
- Counsel patients on the various topical medications used to treat glaucoma
- Identify patients who could benefit from a change or modification in therapy based on pre-existing comorbidities and potential for complications
- Apply strategies for enhancing adherence to patient cases